Article
A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
28 Nov 2024
Abstract excerpt
) hemoglobin switch and is exploited in gene-based therapy for hemoglobin disorders. Because of reliance on ex vivo cell manipulation and marrow transplant, such therapies cannot lessen disease burden. To develop new small-molecule approaches, we investigated the state of BCL11A protein in erythroid cells. We report that tetramer formation mediated by a single zinc finger (ZnF0) is required for production of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
